TLDR:
- Innerspace, a tech startup based in Innsbruck, Austria, raised €5.7M in funding for their risk assessment and training software for pharmaceutical companies.
- The funding round was led by Matterwave Ventures, with participation from MAD Ventures, aws Gründungfonds, and High-Tech Gründerfonds.
Innerspace, based in Innsbruck, Austria, has secured €5.7M in funding for their innovative software and Virtual Reality (VR) technology that enables risk assessment of production processes and effective training of cleanroom personnel for pharmaceutical companies. The funding round was led by Matterwave Ventures, with participation from MAD Ventures, aws Gründungfonds, and High-Tech Gründerfonds. The company plans to use the funds to expand its international market presence and further develop its unique “Frame-by-Frame” technology.
The focus of Innerspace lies in risk assessment and effective training of cleanroom personnel for pharmaceutical companies. By utilizing psychological insights and innovative technologies, the company aims to minimize errors in pharmaceutical processes and reduce risks. Their proprietary method of “Frame-by-Frame Risk Profiling” allows for comprehensive risk assessment, and they offer a standardized cleanroom simulator for personnel training in virtual reality. Innerspace is also an official partner of the Parenteral Drug Association (PDA), actively engaging in the development and implementation of high-quality training courses for the pharmaceutical industry.
